Pharmacodynamic Study on Compatibility of Astragalus Active Ingredients in Diabetes Rats

LI Nan; FAN Ying; JIA Xu-ming; MA Zhe; LIN Shu-ru

您当前的位置：

首页 >

文章列表页 >

Pharmacodynamic Study on Compatibility of Astragalus Active Ingredients in Diabetes Rats

更新时间：2024-01-04

- Pharmacodynamic Study on Compatibility of Astragalus Active Ingredients in Diabetes Rats
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 17, Issue 6, Pages: 150-152(2011)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2011
- 稿件说明：
移动端阅览
LI Nan, FAN Ying, JIA Xu-ming, et al. Pharmacodynamic Study on Compatibility of Astragalus Active Ingredients in Diabetes Rats[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(6): 150-152.
DOI：

LI Nan, FAN Ying, JIA Xu-ming, et al. Pharmacodynamic Study on Compatibility of Astragalus Active Ingredients in Diabetes Rats[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(6): 150-152. DOI：

摘要

目的: 探讨黄芪不同有效部位配伍对糖尿病大鼠血糖、血清胰岛素及脂联素的影响

筛选有效干预糖尿病的黄芪有效部位。方法: SD大鼠ip STZ 52 mg ·kg-1诱导糖尿病模型

分别ig给黄芪及其有效部位的不同配伍

同时设对照组;给药30 d后

以血糖仪测血糖

ELISA法测血清胰岛素、脂联素。结果: 糖尿病模型大鼠体重减轻

血糖升高

血清胰岛素、脂联素水平下降(P＜0.05);酮苷组大鼠体重增加明显(P＜0.05);黄芪组、酮糖组、酮苷组、酮糖苷组血糖降低(P＜0.05)

酮苷组优于糖苷组(P＜0.05);黄芪组升高胰岛素作用显著(P＜0.05);各给药组对血清脂联素均有调节作用(P＜0.05)

以黄芪、酮苷、酮糖苷组作用显著(P＜0.05)。结论: 黄芪及其有效部位的不同配伍调节糖尿病大鼠血糖、血清胰岛素及脂联素水平的作用强度有差异

以黄芪黄酮配伍黄芪皂苷药效较优。

Abstract

Objective: This study was designed to screen different combination of astragalus active ingredients for blood sugar regulation in diabetes rats

and to find the influences on blood glucose

serum insulin and adiponectin. Method: Diabetes rats were induced by STZ (52 mg ·kg-1

peritioneal injection )

some of which were administered by different combination of astragalus flavonoids

polysaccharides

and astragalosides for 30 days

the control group was parallelly established. After the treatment

detection of blood glucose and ELISA assay of serum insulin and adiponectin were carried out. Result: Body weight of diabetes rats was dropped

the blood glucose of diabetes was ascended

serum insulin and adiponectin descended(P<0.05).The blood glucose descended in astragalus flavonoid+astragalosides group (body weight gained for the group); astragalus group

astragalus flavonoid+polysaccharides group

astragalus flavonoid+astragalosides group and astragalus flavonoid+polysaccharides+astragalosides group. The best group was astragalus group for ascending serum insulin(P<0.05). The treatment groups showed regulative effect on serum adiponectin

the effect of astragalus group

astragalus flavonoid+astragalosides group and astragalus flavonoid+polysaccharides+astragalosides group were obvious(P<0.05). Conclusion: Astragalus and different combination of its active ingredients could influence the content of blood glucose

serum insulin and adiponectin in diabetes rats

the best result came from astragalus flavonoid+astragalosides group.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Astragali Radix Active Ingredients on Serum Insulin and Adiponectin in Diabetes Rats

Effects of Total Saponins from Balsam Pear on Insulin Resistance, Adiponectin and Leptin in Rat Model of Type 2 Diabetes

Experimental Study on Hypoglycemic Effect of Jingshenguo Granule in Type 2 Diabetic Rats

Effect of Siraitiae Fructus Extracts from Different Growth Period Fruit on Postprandial Blood Glucose in Mice

Related Author

LI Nan1

FAN Ying1

JIA Xu-ming1

MA Zhe1

LIN Shu-ru2

LIU Yong-sheng

LI Xiao-kun

WANG Jin-ju

Related Institution

Prescriptions Module,Liaoning University of Traditional Chinese Medicine

Molecular Biology Laboratory,Liaoning University of Traditional Chinese Medicine

Guangxi University of Chinese Medicine

Guilin Jiqi Shili Natural Plant Science & Technology Co.

School of Chinese Pharmaceutical Science,Guangzhou University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰